Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
Clinical trial NCT03524235 · COMPLETED
Trial details
- NCT number
- NCT03524235
- Sponsor
- Noah Merin
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-18
- Primary completion
- 2021-11-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.